BOUL — Boule Diagnostics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK388.33m
- SEK517.22m
- SEK571.33m
- 90
- 77
- 69
- 93
Annual cashflow statement for Boule Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 70 | -5.93 | 36 | 29 | 39.3 |
| Depreciation | |||||
| Non-Cash Items | 6.38 | 31.4 | -2.03 | -4.11 | 29.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -43.8 | 28.3 | -12.2 | -63.4 | -17.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 54 | 75.2 | 43.3 | -11.4 | 51.4 |
| Capital Expenditures | -6.1 | -4.58 | -3.15 | -6.43 | -6.87 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -68.4 | -41.4 | -53.2 | -68.5 | -75.8 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -74.5 | -46 | -56.4 | -75 | -82.7 |
| Financing Cash Flow Items | — | 0.001 | -0.001 | -10.3 | -0.56 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.6 | -14.9 | 15.8 | 141 | -25.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.68 | 11.4 | 5.19 | 58.7 | -59.6 |